Fundraising Fox
Fusmobile
Founded 2014 · 22 employees on LinkedIn · 2 known investors
Find your way into Fusmobile
Sign up to find every way you can get introduced to Fusmobile
- Your email: who you already know at Fusmobile, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Fusmobile team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.
Investors · 2
Frequently asked questions
- What does Fusmobile do?
- FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.
- Who are Fusmobile's investors?
- Fusmobile's investors include Atlanta Technology Angels, OrbiMed.